Answers to frequently asked questions about migraine.
Migraine is a common primary headache disorder associated with pronounced disability and hence marked economic and public health Implications. Appropriate treatment is warranted to limit the associated disability migraineurs experience. Because of the heterogeneity of migraine, treatment plans must be individualized. The purpose of this article is to provide answers to frequently asked questions regarding the management of migraine.
Garza
Ivan
I
Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA. garzaurdiales.ivan@mayo.edu
Swanson
Jerry W
JW
D000700:Analgesics / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D014363:Tryptamines / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D000700:Analgesics; D014363:Tryptamines; D014662:Vasoconstrictor Agents; D001905:Botulinum Toxins